Drug Type Small molecule drug, Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Target |
Mechanism BRPF2 modulators(bromodomain containing 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H19FN4O3 |
InChIKeyVVQORRVLAWIWLO-GJQNQZCXSA-N |
CAS Registry3032314-28-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Preclinical | US | 08 Jan 2021 |